Business development

Cantargia’s business concept is the in-house development of candidate products until evidence of clinical activity has been obtained. The first product to have reached the clinical trial stage is CAN04, with the CANFOUR study as a value-enhancing activity in future partner discussions.

We are always open to dialogue with potential partners.